NCT05778396

Brief Summary

This study aims to compare two different spinal manual therapy interventions of the back to determine if they are viable and acceptable for a future study investigating the treatment of patients with back pain. The two proposed spinal manual therapy interventions are widely used in the fields of chiropractic, physical therapy, osteopathy, and manual medicine to treat back pain and improve function. This is a randomized study, meaning that participants are randomly assigned (like tossing a coin) to one of two manual spinal therapy interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

March 21, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

April 4, 2023

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2023

Completed
Last Updated

June 2, 2023

Status Verified

June 1, 2023

Enrollment Period

21 days

First QC Date

February 27, 2023

Last Update Submit

June 1, 2023

Conditions

Keywords

MethodsManual therapyRandomized trialBack painBlinding assessment

Outcome Measures

Primary Outcomes (2)

  • Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 1.

    The blinding assessment survey item will ask: "Which treatment do you believe you received?" with five response options provided: "Strongly believe I received the genuine treatment," "Somewhat believe I received the genuine treatment," "Somewhat believe I received the control treatment," "Strongly believe I received the control treatment," and "I do not know which treatment I received." Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm. For the Bang BI, a score with an absolute value of ≤0.3 (i.e., -0.3 to 0.3) will be deemed compatible with satisfactory blinding, and blinding scenarios will be discussed.

    Immediately after intervention session 1 (study day 1)

  • Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 2.

    The blinding assessment survey item will ask: "Which treatment do you believe you received?" with five response options provided: "Strongly believe I received the genuine treatment," "Somewhat believe I received the genuine treatment," "Somewhat believe I received the control treatment," "Strongly believe I received the control treatment," and "I do not know which treatment I received." Bang BI estimates (between -1 to +1, with 0 indicating satisfactory blinding) can be interpreted as the proportion of correct guesses beyond chance within an intervention arm. For the Bang BI, a score with an absolute value of ≤0.3 (i.e., -0.3 to 0.3) will be deemed compatible with satisfactory blinding, and blinding scenarios will be discussed.

    Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

Secondary Outcomes (6)

  • Participant blinding success, as measured by the validated James blinding index, immediately after intervention session 1.

    Immediately after intervention session 1 (study day 1)

  • Participant blinding success, as measured by the validated James blinding index, immediately after intervention session 2.

    Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

  • Outcome assessor blinding success, as measured by the validated Bang index, immediately after intervention session 1.

    Immediately after intervention session 1 (study day 1)

  • Outcome assessor blinding success, as measured by the validated Bang index, immediately after intervention session 2.

    Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

  • Outcome assessor blinding success, as measured by the validated James index, immediately after intervention session 1.

    Immediately after intervention session 1 (study day 1)

  • +1 more secondary outcomes

Other Outcomes (31)

  • Lumbar spine range of motion, immediately before intervention session 1.

    Immediately before intervention session 1 (study day 1)

  • Lumbar spine range of motion, immediately after intervention session 1.

    Immediately after intervention session 1 (study day 1)

  • Lumbar spine range of motion, immediately before intervention session 2.

    Immediately before intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)

  • +28 more other outcomes

Study Arms (2)

Active spinal manual therapy protocol

ACTIVE COMPARATOR

(1) Side-lying lumbar spine manipulation, (2) prone lumbar spine mobilization, and (3) prone thoracic spine manipulation.

Procedure: Active spinal manual therapy protocol

Control spinal manual therapy protocol

SHAM COMPARATOR

(1) Control side-lying lumbar spine manipulation, (2) control prone lumbar spine mobilization, and (3) control prone thoracic spine manipulation.

Procedure: Control spinal manual therapy protocol

Interventions

The chiropractor will start by (1) placing one hand over L4-L5 or L5-S1 and then will apply a high-velocity, low-amplitude (HVLA) thrust with a therapeutic line of drive. Side-lying lumbar manipulation will be performed bilaterally, with the treating clinician choosing any suitable technique and with or without occurrence of the characteristic audible joint cavitation associated with spine manipulation. The chiropractor will then perform (2) prone lumbar mobilisation by placing the contact hand and applying downward pressure over L4-L5 or L5-S1 with the other hand guiding a manual flexion-distraction piece to apply therapeutic mobilization of the lumbar spine. The chiropractor will deliver (3) a prone thoracic manipulation by placing two hands over the transverse processes of T5-T6 or T6-T7 and applying a HVLA thrust in a posterior-to-anterior direction.

Active spinal manual therapy protocol

(1) Control side-lying lumbar manipulation will be operationalised as the application of a low-velocity broad push manoeuvre to the gluteal region following a non-therapeutic line of drive. The chiropractor will then perform (2) control prone lumbar mobilisation, consisting of a non-therapeutic manual manoeuvre involving minimal oscillations (0 to ±2°) of the flexion-distraction piece with light touch over the lumbar spine region, and (3) control prone thoracic mobilisation consisting of two-handed left and right scapula pushes with a nontherapeutic line of drive.

Control spinal manual therapy protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • With or without experience of spinal manual therapy
  • With or without experience of current low back pain

You may not qualify if:

  • Serious spinal pathology (e.g. spinal fracture, cancer or infection)
  • History of lumbar spine surgery
  • Currently under care or in consultation with a specialist, chiropractor, physiotherapist, or osteopath for current back pain
  • Manual medicine health care provider (i.e., chiropractor, physiotherapist, osteopath, massage therapist, manual medicine trained physician)
  • Have a serious comorbidity preventing them from attending the research clinic and receiving the interventions
  • Pregnant or breastfeeding status
  • Involved in pending litigation related to back pain
  • Already participating in another research study related to back pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balgrist University Hospital and CHIROMED Praxis im Seefeld

Zurich, 8008, Switzerland

Location

Related Publications (2)

  • Munoz Laguna J, Kurmann A, Hofstetter L, Nyantakyi E, Braun J, Clack L, Bang H, Farshad M, Foster NE, Puhan MA, Hincapie CA; SALuBRITY Blinding Clinician Group. 'Which treatment do you believe you received?' A randomised blinding feasibility trial of spinal manual therapy. Chiropr Man Therap. 2025 Jan 14;33(1):4. doi: 10.1186/s12998-024-00561-0.

  • Munoz Laguna J, Kurmann A, Hofstetter L, Nyantakyi E, Clack L, Bang H, Foster NE, Braun J, Puhan MA, Farshad M, Hincapie CA. Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial. Pilot Feasibility Stud. 2024 May 2;10(1):70. doi: 10.1186/s40814-024-01492-6.

MeSH Terms

Conditions

Back PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Cesar A Hincapié, DC PhD

    Balgrist University Hospital and University of Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants, managing clinicians, outcome assessors, data analysts, and investigators will be blinded to intervention assigned. Only treating clinicians will not be blinded to the interventions but will be trained and asked not to disclose the intervention, nature of the interventions, nor trial objectives to trial participants or other members of the trial team.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Two-parallel-group, single-centre, sham-controlled, methodological blinding feasibility randomised trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Scientist and Head of Musculoskeletal Epidemiology Research

Study Record Dates

First Submitted

February 27, 2023

First Posted

March 21, 2023

Study Start

April 4, 2023

Primary Completion

April 25, 2023

Study Completion

April 25, 2023

Last Updated

June 2, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

The central contact person and principal investigator will make supporting information available upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE

Locations